GRITSTONE BIO, INC.

Analyst Reco. Gritstone bio, Inc.

Equities

GRTS

US39868T1051

Real-time Estimate Cboe BZX Other stock markets 10:54:48 2024-06-10 am EDT			5-day change	1st Jan Change
0.745 ^USD	-0.08%		-0.59%	-64.22%

Jun. 01	Certain Restricted Stock Units of Gritstone bio, Inc. are subject to a Lock-Up Agreement Ending on 1-JUN-2024.	CI
Jun. 01	Certain Stock Options of Gritstone bio, Inc. are subject to a Lock-Up Agreement Ending on 1-JUN-2024.	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Cuts Price Target on Gritstone bio to $3 From $6, Keeps Buy Rating	May. 24	MT
B. Riley Adjusts Gritstone bio's Price Target to $6 From $8, Keeps Buy Rating	Dec. 07	MT
Piper Sandler Lifts Price Target on Gritstone bio to $7 From $6, Keeps Overweight Rating	23-09-28	MT
B. Riley Initiates Coverage of Gritstone bio With Buy Rating, Price Target of $8 Per Share	23-03-28	MT
HC Wainwright Adjusts Gritstone bio's Price Target to $7 From $12, Keeps Buy Rating	22-11-07	MT
Piper Sandler Starts Gritstone bio at Overweight With $6 Price Target	22-10-31	MT
Goldman Sachs Downgrades Gritstone bio to Sell From Neutral; Price Target is $2	22-08-22	MT
HC Wainwright Lowers Gritstone bio's Price Target to $12 From $15, Maintains Buy Rating	22-05-09	MT
HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Rating	22-03-14	MT
GRITSTONE ONCOLOGY : BTIG Research Adjusts Gritstone Oncology PT to $35 From $17, Maintains Buy Rating	21-01-21	MT
GRITSTONE ONCOLOGY : HC Wainwright Adjusts Gritstone Oncology's Price Target to $24 from $16, Keeps Buy Rating	21-01-20	MT
GRITSTONE ONCOLOGY : Baird Downgrades Gritstone Oncology to Underperform From Outperform; Price Target is $8	21-01-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer